Cargando…
Comparing survival functions with interval-censored data in the presence of an intermediate clinical event
BACKGROUND: In the presence of an intermediate clinical event, the analysis of time-to-event survival data by conventional approaches, such as the log-rank test, can result in biased results due to the length-biased characteristics. METHODS: In the present study, we extend the studies of Finkelstein...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167867/ https://www.ncbi.nlm.nih.gov/pubmed/30285636 http://dx.doi.org/10.1186/s12874-018-0558-y |
Sumario: | BACKGROUND: In the presence of an intermediate clinical event, the analysis of time-to-event survival data by conventional approaches, such as the log-rank test, can result in biased results due to the length-biased characteristics. METHODS: In the present study, we extend the studies of Finkelstein and Nam & Zelen to propose new methods for handling interval-censored data with an intermediate clinical event using multiple imputation. The proposed methods consider two types of weights in multiple imputation: 1) uniform weight and 2) the weighted weight methods. RESULTS: Extensive simulation studies were performed to compare the proposed tests with existing methods regarding type I error and power. Our simulation results demonstrate that for all scenarios, our proposed methods exhibit a superior performance compared with the stratified log-rank and the log-rank tests. Data from a randomized clinical study to test the efficacy of sorafenib/sunitinib vs. sunitinib/sorafenib to treat metastatic renal cell carcinoma were analyzed under the proposed methods to illustrate their performance on real data. CONCLUSIONS: In the absence of intensive iterations, our proposed methods show a superior performance compared with the stratified log-rank and the log-rank test regarding type I error and power. |
---|